Get In Touch
info@pbgbiopharma.com
Work Inquiries
info@pbgbiopharma.com

Legalized Cannabis Dispensaries Linked to Fewer Opioid Deaths

A recent study examined the association between the cannabis dispensary counts and opioid related mortality rates in 812 counties in the US. The study found that higher storefront dispensary counts are associated with reduced opioid related death rates, particularly deaths associated with synthetic opioids such as fentanyl. An increase from one to two storefront dispensaries in a county is associated with an estimated 17% reduction in all opioid related mortality rates.

Read more here: https://pbgcannabis.com/news/blog/

Reference:

1.            Hsu, G. & Kovács, B. Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study. BMJ 372, m4957 (2021). https://www.bmj.com/content/372/bmj.m4957

close

The freshest cannabis content, right to your inbox.

Sign up to receive the latest developments in cannabis science every week.

We don’t spam! Read our privacy policy for more info.

Author avatar
Dr. Dan Jin
Dr. Dan Jin is the resident Cannabis Research Scientist at PBG BioPharma. She has over 10 publications to her name in the field of cannabis research. She is a passionate force in researching novel uses of cannabis and educating the public about the potential of this incredible plant.

Post a comment

Your email address will not be published. Required fields are marked *

We use cookies to give you the best experience.